Benitec Biopharma Inc.·4

Dec 3, 4:17 PM ET

Francis Peter 4

4 · Benitec Biopharma Inc. · Filed Dec 3, 2025

Insider Transaction Report

Form 4
Period: 2025-12-01
Transactions
  • Award

    Options (right to buy)

    2025-12-01+35,00035,000 total
    Exercise: $12.23Exp: 2035-12-01Common Stock (35,000 underlying)
Footnotes (1)
  • [F1]The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES